🇺🇸 FDA
Patent

US 7179826

Compositions useful as inhibitors of protein kinases

granted A61PA61P19/00A61P3/00

Quick answer

US patent 7179826 (Compositions useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P19/00, A61P3/00, A61P31/12, A61P35/00